Vangelis Manolopoulos

Cited by

	All	Since 2019
Citations	5534	1863
h-index	38	23
i10-index	104	55

360

180

270

199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202414 25 20 32 56 92 96 91 88 72 96 81 74 84 97 111 178 186 229 237 319 342 326 313 318 316 275 343 327 294 303

Public access

View all

13 articles

6 articles

available

not available

Based on funding mandates

Co-authors

Anna TavridouAssociate ProfessorVerified email at med.duth.gr
Arvanitidis K.Democritus University of ThraceVerified email at med.duth.gr
Talitha Scherpenzeel-VerhoefVerified email at ucl.ac.uk
Bernd NiliusKU LeuvenVerified email at med.kuleuven.be
Peter I LelkesLaura H. Carnell Professor and Chair, Dept. Bioengineering, Temple UniversityVerified email at temple.edu
Ann DalyProfessor of Pharmacogenetics, Newcastle UniversityVerified email at ncl.ac.uk
Ron van SchaikProfessor Pharmacogenetics, ErasmusVerified email at erasmusmc.nl
Adrián LLerena MD PhD Professor Cli...INUBE Biosanitary University Research Institute. University of Extremadura. CICAB Clinical ResearchVerified email at unex.es
Munir PirmohamedUniversity of LiverpoolVerified email at liv.ac.uk
Frits Rosendaalhoogleraar Klinische Epidemiologie, Leiden University Medical CenterVerified email at lumc.nl
Thomas VoetsKU Leuven Department of Cellular and Molecular Medicine and VIB Center for Brain & Disease ResearchVerified email at kuleuven.vib.be
Saskia le CessieLeids Universitair Medisch CentrumVerified email at lumc.nl
Prof. David GurwitzDept. Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv UniversityVerified email at post.tau.ac.il
Maurizio SimmacoUniversità La Sapienza - Azienda Ospedaliera Sant'Andrea - RomaVerified email at uniroma1.it
Peristera PaschouProfessor, Department of Biological Sciences, Purdue UniversityVerified email at purdue.edu
Efstratios MaltezosDemocritus University of ThraceVerified email at med.duth.gr
Andreas PapapetropoulosNational and Kapodistrian University of AthensVerified email at pharm.uoa.gr
Jan EggermontFaculty of medicine, University of LeuvenVerified email at kuleuven.be
Ploumis PassadakisDemocritus University of Thrace, Medical SchoolVerified email at med.duth.gr
Stavros KonstantinidesDepartment of Cardiology, Democritus University of Thrace, GreeceVerified email at med.duth.gr

Vangelis Manolopoulos

Professor of Pharmacology, Pharmacogenomics, and Precision Medicine, Democritus University of Thrace

Verified email at med.duth.gr

pharmacogenomics personalised medicine cardiovascular pharmacology diabetes anticoagulant drugs


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Properties of volume-regulated anion channels in mammalian cells B Nilius, J Eggermont, T Voets, G Buyse, V Manolopoulos, G Droogmans Progress in biophysics and molecular biology 68 (1), 69-119, 1997	427	1997
A randomized trial of genotype-guided dosing of acenocoumarol and phenprocoumon TI Verhoef, G Ragia, A de Boer, R Barallon, G Kolovou, V Kolovou, ... New England Journal of Medicine 369 (24), 2304-2312, 2013	265	2013
Realities and expectations of pharmacogenomics and personalized medicine: impact of translating genetic knowledge into clinical practice A Squassina, M Manchia, VG Manolopoulos, M Artac, C Lappa-Manakou, ... Pharmacogenomics 11 (8), 1149-1167, 2010	188	2010
Genetic polymorphisms of drug‐metabolizing enzymes CYP2D6, CYP2C9, CYP2C19 and CYP3A5 in the Greek population K Arvanitidis, G Ragia, M Iordanidou, S Kyriaki, A Xanthi, A Tavridou, ... Fundamental & clinical pharmacology 21 (4), 419-426, 2007	188	2007
Regulation of a swelling-activated chloride current in bovine endothelium by protein tyrosine phosphorylation and G proteins T Voets, V Manolopoulos, J Eggermont, C Ellory, G Droogmans, B Nilius The Journal of Physiology 506 (Pt 2), 341, 1998	183	1998
Genotype-guided dosing of coumarin derivatives: the European pharmacogenetics of anticoagulant therapy (EU-PACT) trial design RMF Van Schie, MIA Wadelius, F Kamali, AK Daly, VG Manolopoulos, ... Pharmacogenomics 10 (10), 1687-1695, 2009	171	2009
A global view of the OCA2-HERC2 region and pigmentation MP Donnelly, P Paschou, E Grigorenko, D Gurwitz, C Barta, RB Lu, ... Human genetics 131, 683-696, 2012	170	2012
Pharmacogenomics education: International Society of Pharmacogenomics recommendations for medical, pharmaceutical, and health schools deans of education D Gurwitz, JE Lunshof, G Dedoussis, CS Flordellis, U Fuhr, J Kirchheiner, ... The pharmacogenomics journal 5 (4), 221-225, 2005	147	2005
Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies G Ragia, VG Manolopoulos European journal of clinical pharmacology 76, 1623-1630, 2020	120	2020
Presence of CYP2C93* Allele Increases Risk for Hypoglycemia in Type 2 Diabetic Patients Treated with Sulfonylureas G Ragia, I Petridis, A Tavridou, D Christakidis, VG Manolopoulos Pharmacogenomics 10 (11), 1781-1787, 2009	120	2009
The association of adipokine levels in plasma and synovial fluid with the severity of knee osteoarthritis C Staikos, A Ververidis, G Drosos, VG Manolopoulos, DA Verettas, ... Rheumatology 52 (6), 1077-1083, 2013	117	2013
Characterisation of explanted endothelial cells from mouse aorta: electrophysiology and Ca²⁺ signalling SH Suh, R Vennekens, VG Manolopoulos, M Freichel, U Schweig, ... Pflügers Archiv 438, 612-620, 1999	103	1999
Pharmacogenetics of coumarinic oral anticoagulants VG Manolopoulos, G Ragia, A Tavridou Pharmacogenomics 11 (4), 493-496, 2010	99	2010
Cardioprotection by H2S donors: nitric oxide-dependent and‑independent mechanisms A Chatzianastasiou, SI Bibli, I Andreadou, P Efentakis, N Kaludercic, ... Journal of Pharmacology and Experimental Therapeutics 358 (3), 431-440, 2016	96	2016
Need for Reassessment of Reported CYP2C19 Allele Frequencies in Various Populations in View of CYP2C1917* Discovery: The Case of Greece G Ragia, KI Arvanitidis, A Tavridou, VG Manolopoulos Pharmacogenomics 10 (1), 43-49, 2009	94	2009
The serotonin transporter promoter polymorphism (5-HTTLPR) is associated with type 2 diabetes M Iordanidou, A Tavridou, I Petridis, KI Arvanitidis, D Christakidis, ... Clinica Chimica Acta 411 (3-4), 167-171, 2010	89	2010
Pharmacogenomics of oral antidiabetic medications: current data and pharmacoepigenomic perspective VG Manolopoulos, G Ragia, A Tavridou Pharmacogenomics 12 (8), 1161-1191, 2011	88	2011
The distribution and most recent common ancestor of the 17q21 inversion in humans MP Donnelly, P Paschou, E Grigorenko, D Gurwitz, SQ Mehdi, ... The American Journal of Human Genetics 86 (2), 161-171, 2010	87	2010
Expression patterns of sarco/endoplasmic reticulum Ca2+-ATPase and inositol 1, 4, 5-trisphosphate receptor isoforms in vascular endothelial cells I Mountian, VG Manolopoulos, H De Smedt, JB Parys, L Missiaen, ... Cell Calcium 25 (5), 371-380, 1999	85	1999
Tissue factor activity is upregulated in human endothelial cells exposed to oscillatory shear stress L Mazzolai, P Silacci, K Bouzourene, F Daniel, H Brunner, D Hayoz Thrombosis and haemostasis 87 (06), 1062-1068, 2002	73	2002

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors